<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">1463</journal-id><journal-id journal-id-type="pmc-domain">frontpsychiat</journal-id><journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id><journal-title-group><journal-title>Frontiers in Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1664-0640</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10711089</article-id><article-id pub-id-type="pmcid-ver">PMC10711089.1</article-id><article-id pub-id-type="pmcaid">10711089</article-id><article-id pub-id-type="pmcaiid">10711089</article-id><article-id pub-id-type="pmid">38090703</article-id><article-id pub-id-type="doi">10.3389/fpsyt.2023.1243124</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Psychiatry</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Anti-depressant medication use is a risk factor for incident knee surgery and opioid use in patients with knee osteoarthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zheng</surname><given-names initials="Y">Yongqiang</given-names></name><xref rid="fn001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2016213/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jinshan</given-names></name><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2343455/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zefeng</given-names></name><xref rid="fn003" ref-type="author-notes">
<sup>&#8224;</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="X">Xiaofeng</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2353067/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="Y">Yongquan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fang</surname><given-names initials="Y">Yangzhen</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2045485/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="Z">Zhenyu</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="L">Liang</given-names></name><xref rid="fn004" ref-type="author-notes">
<sup>&#8224;</sup>
</xref></contrib></contrib-group><aff><institution>Department of Orthopedics, Jinjiang Municipal Hospital</institution>, <addr-line>Fujian</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Roberto Ciccocioppo, University of Camerino, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Hongyi Zhu, Shanghai Jiao Tong University, China; Changqing Zhang, Shanghai Jiao Tong University, China</p></fn><corresp id="c001">*Correspondence: Jinshan Zhang <email>zhangjinshan193@sina.com</email></corresp><fn fn-type="other" id="fn001"><p>&#8224;ORCID: Yongqiang Zheng <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-9780-3808" ext-link-type="uri">orcid.org/0000-0002-9780-3808</ext-link></p></fn><fn fn-type="other" id="fn002"><p>Jinshan Zhang <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0000-8412-2424" ext-link-type="uri">orcid.org/0009-0000-8412-2424</ext-link></p></fn><fn fn-type="other" id="fn003"><p>Zefeng Wang <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0001-6433-9244" ext-link-type="uri">orcid.org/0009-0001-6433-9244</ext-link></p></fn><fn fn-type="other" id="fn004"><p>Liang Lin <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0009-0007-9195-6671" ext-link-type="uri">orcid.org/0009-0007-9195-6671</ext-link></p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">427509</issue-id><elocation-id>1243124</elocation-id><history><date date-type="received"><day>21</day><month>6</month><year>2023</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>11</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>12</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-29 00:25:09.870"><day>29</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Zheng, Zhang, Wang, Liu, Xu, Fang, Lin and Lin.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zheng, Zhang, Wang, Liu, Xu, Fang, Lin and Lin</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fpsyt-14-1243124.pdf"/><abstract><sec><title>Objective</title><p>To investigate whether depression and exposure to anti-depressant medication are independent risk factors for incident knee surgery and opioid use in knee osteoarthritis (KOA) patients.</p></sec><sec><title>Methods</title><p>We identified all patients who visited our outpatient department and were clinically diagnosed with KOA between January 2010 and January 2018. We retrieved their demographic, clinical, and radiographic data from the database of our hospital. Next, we analyzed the effect of depression and anti-depressant medication on the incident knee surgery and opioid use in KOA patients.</p></sec><sec><title>Results</title><p>A total of 4,341 KOA patients were found eligible to form the study population. Incident knee surgery and opioid use for the purpose of treating osteoarthritis were observed in 242 and 568 patients, respectively. Incident knee surgery was significantly associated with age (OR [95%CI], 1.024 [1.009&#8211;1.039], <italic toggle="yes">P</italic> = 0.002), BMI (OR [95%CI], 1.090 [1.054&#8211;1.128], <italic toggle="yes">P</italic> &lt; 0.001), baseline K-L grade 3 (OR [95%CI], 1.977 [1.343&#8211;2.909], <italic toggle="yes">P</italic> = 0.001), baseline K-L grade 4 (OR [95%CI], 1.979 [1.241&#8211;3.157], <italic toggle="yes">P</italic> = 0.004), depression (OR [95%CI], 1.670 [1.088&#8211;2.563], <italic toggle="yes">P</italic> = 0.019), and exposure to anti-depressant medication (OR [95%CI], 2.004 [1.140&#8211;3.521], <italic toggle="yes">P</italic> = 0.016). Incident opioid use was significantly associated with depression (OR [95%CI], 1.554 [1.089&#8211;2.215], <italic toggle="yes">P</italic> = 0.015) and exposure to anti-depressant medication (OR [95%CI], 1.813 [1.110&#8211;2.960], <italic toggle="yes">P</italic> = 0.017).</p></sec><sec><title>Conclusion</title><p>Depression and anti-depressant drug exposure were independently associated with incident knee surgery, highlighting the need for more attention on comorbid depression in KOA management.</p></sec></abstract><kwd-group><kwd>KOA</kwd><kwd>anti-depressant</kwd><kwd>risk factor</kwd><kwd>knee surgery</kwd><kwd>opioid</kwd><kwd>depression</kwd></kwd-group><funding-group><funding-statement>The study was funded by the Shanghai Shen Kang Hospital Development Centre, the Clinical Research Plan of SHDC (Grant Number: SHDC2020CR6019), and the Science and Technology Project of Quanzhou City (2020N079s).</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="44"/><page-count count="6"/><word-count count="4362"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Psychopharmacology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Knee osteoarthritis (KOA) is a prevalent and disabling disease characterized by the structural degradation of cartilage, persistent pain, joint stiffness, and functional limitations, affecting more than 10% of the overall population as estimated (<xref rid="B1" ref-type="bibr">1</xref>&#8211;<xref rid="B3" ref-type="bibr">3</xref>). According to the Global Burden of Disease Study 2019 (<xref rid="B4" ref-type="bibr">4</xref>), because of the increase in the aging population, the disease burden of KOA has been rapidly growing worldwide over the past decades (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Depression is also a major challenge for medical society with rapidly increasing disease burden in recent decades (<xref rid="B6" ref-type="bibr">6</xref>). Studies conducted in different countries consistently showed that depression is greatly more prevalent among patients with osteoarthritis (<xref rid="B7" ref-type="bibr">7</xref>&#8211;<xref rid="B9" ref-type="bibr">9</xref>). Thus, there is a huge population affected by depression and osteoarthritis simultaneously. A previous study showed that more than 20% of patients with osteoarthritis had depressive symptoms (<xref rid="B10" ref-type="bibr">10</xref>). Notably, a recent study revealed a huge care gap in this large population that only half of KOA patients with comorbid depression received mental health (<xref rid="B11" ref-type="bibr">11</xref>). Conversely, depression largely contributed to rapid progression (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Therefore, the interplay between KOA and depression and depression-related medications should be investigated with urgency (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>Opioids are recommended by multiple guidelines for the management of KOA pain after failure of other pain-relieving medications (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). However, the misuse and abuse of opioid medications is an emerging challenge over the past two decades (<xref rid="B16" ref-type="bibr">16</xref>). Many factors are associated with this issue, including aggressive pain control and inappropriate prescription (<xref rid="B17" ref-type="bibr">17</xref>). Both depression and osteoarthritis were deeply involved in this opioid abuse/misuse epidemic (<xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B20" ref-type="bibr">20</xref>). Opioid exposure in KOA patients contributed to increased medical cost, impaired productivity, potential for abuse, and increased mortality (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). Therefore, reducing prolonged opioid use may lead to a meaningful reduction in social and economic costs for KOA patients (<xref rid="B19" ref-type="bibr">19</xref>). However, depressed patients are at substantial risk of prolonged opioid use (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B23" ref-type="bibr">23</xref>). In addition, the severity of depression is closely associated with opioid-related problems (<xref rid="B24" ref-type="bibr">24</xref>). Opioid use itself also contributed to new onset and progression of depression (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>).</p><p>The aims of this study were, therefore, to determine whether depression and exposure to anti-depressant medications were associated with the incidence of knee surgery and opioid use.</p></sec><sec id="s2"><title>Patients and methods</title><sec><title>Study population</title><p>We identified all patients who visited our outpatient department and were clinically diagnosed as KOA between January 2010 and January 2018 using the hospital information system (HIS). The clinical diagnosis of KOA was made by clinical specialists in orthopedic and/or sports medicine. It was generally determined based on patient history, physical examination, and laboratory and radiographic findings (<xref rid="B27" ref-type="bibr">27</xref>). Patients were excluded from this study if they had structural knee injuries (fractures, ligament ruptures, meniscal tears, and dislocations) (<italic toggle="yes">n</italic> = 345), any knee surgery histories (<italic toggle="yes">n</italic> = 125), missing values for baseline variables (<italic toggle="yes">n</italic> = 567), and declined to participate (<italic toggle="yes">n</italic> = 1,152). Our study adhered to the Declaration of Helsinki and all local laws and regulations, and we obtained ethics approval for collecting all related data.</p></sec><sec><title>Baseline patient data</title><p>To better assess the radiographic severity of KOA, we defined the baseline as the time of performing the first knee plain radiograph during the study period. All baseline demographic and clinical data were retrieved from HIS, and the information was further confirmed by contacting patients by all possible means. The baseline demographic data consisted of demographic information [age, sex, body mass index (BMI)] and education. The Kellgren&#8211;Lawrence (K-L) grades (<xref rid="B28" ref-type="bibr">28</xref>) were rated by a radiographic evaluation committee consisting of three radiologists specialized in musculoskeletal radiology. The rating process was conducted without grouping information. The consensus on grading was achieved by the majority. When the two knees had different K-L grades, the final K-L grade was recorded according to the more severe side. Generally, in our institution, we treated KOA patients initially with topical or oral NSAIDs. When the initial treatment fails, we would recommend intra-articular therapies and opioid medication based on the preferences of patients.</p></sec><sec><title>Depression and anti-depressant drugs</title><p>The diagnosis of depression and exposure to anti-depressant drugs, including selective serotonin reuptake inhibitors (SSRIs), tricyclic anti-depressants (TCAs), and serotonin-norepinephrine reuptake inhibitors (SNRI), were first reported by patients and further confirmed by reviewing their medical records.</p></sec><sec><title>Definition of incident knee surgery and opioid exposure</title><p>The incident knee surgery and types of surgery were reported by patients. The incident knee surgery was defined as any surgical procedure performed to treat KOA, no matter whether this type of surgical procedure was recommended or not. Incident knee surgery in the current study included knee arthroplasty, arthroscopic procedures, and high tibial osteotomy (HTO). The efficacy and safety of arthroplasty and HTO have been well-established and generally recommended for KOA management (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). However, although many high-quality randomized trials have consistently demonstrated that arthroscopic procedures, including lavage, debridement, and arthroscopic partial meniscectomy, are ineffective and even harmful for KOA patients by accelerating joint destruction and increasing future arthroplasty risks, these high-quality evidence most published in leading medical journals have failed to prevent surgeons from performing arthroscopic procedures for managing KOA (<xref rid="B31" ref-type="bibr">31</xref>&#8211;<xref rid="B34" ref-type="bibr">34</xref>). We, therefore, also considered incident arthroscopic procedures as clinically important events of poor symptom control and disease progression. Incident opioid exposure was defined as the initiation of opioid use during the study period for opioid-na&#239;ve patients at baseline. The opioid exposure history was reported by patients and confirmed by reviewing their medical records by researchers.</p></sec><sec><title>Statistical analysis</title><p>All statistical analyses were performed using SPSS software (26.0, IBM, Chicago, USA). The statistical significance was set at a two-sided 0.05. We first tabulated descriptive statistics to summarize the characteristics of the subjects. Continuous and categorical variables were, respectively, presented as means &#177; standard deviations and counts (percentage), unless otherwise indicated. When the yielded <italic toggle="yes">P</italic>-value was less than 0.2 in univariable analysis, the variables along with demographic variables (age, sex, and BMI) were further included in logistic regression for multivariable analysis.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>The association between depression/anti-depressant medication and incident knee surgery</title><p>A total of 4,341 KOA patients were found eligible for the final analysis. Incident knee surgery to treat osteoarthritis was observed in 242 patients. Specifically, 70 patients had knee arthroplasty, 162 had arthroscopic procedure, and 10 had high tibial osteotomy. Of the 179 patients with exposure to anti-depressant medication, 146 patients used these drugs for their depressive disorders, 20 for Alzheimer's disease, 6 for obsessive-compulsive disorder, 4 for phobia, and 3 for other mental disorders. For univariable analyses, incident knee surgery was significantly associated with age, BMI, baseline K-L grades, depression, and exposure to anti-depressant medication (<xref rid="T1" ref-type="table">Table 1</xref>). For multivariable analysis, incident knee surgery was significantly associated with age (OR [95%CI], 1.024 [1.009&#8211;1.039], <italic toggle="yes">P</italic> = 0.002), BMI (OR [95%CI], 1.090 [1.054&#8211;1.128], <italic toggle="yes">P</italic> &lt; 0.001), baseline K-L grade 3 (OR [95%CI], 1.977 [1.343&#8211;2.909], <italic toggle="yes">P</italic> = 0.001), baseline K-L grade 4 (OR [95%CI], 1.979 [1.241&#8211;3.157], <italic toggle="yes">P</italic> = 0.004), depression (OR [95%CI], 1.670 [1.088&#8211;2.563], <italic toggle="yes">P</italic> = 0.019), and exposure to anti-depressant medication (OR [95%CI], 2.004 [1.140&#8211;3.521], <italic toggle="yes">P</italic> = 0.016; <xref rid="T2" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Univariable analysis on characteristics grouped by incident knee surgery.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<bold>No incident knee surgery (<italic toggle="yes">n</italic> = 4,099)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold>Incident knee surgery (<italic toggle="yes">n</italic> = 242)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic toggle="yes">P-</italic>value</bold>
</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="center" rowspan="1" colspan="1">61.02 &#177; 8.83</td><td valign="top" align="center" rowspan="1" colspan="1">62.93 &#177; 8.46</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Sex, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">1,068 (26.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">70 (28.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.324</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">3,031 (73.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">170 (71.1%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Baseline BMI, kg/m<sup>2</sup></td><td valign="top" align="center" rowspan="1" colspan="1">25.07 &#177; 3.59</td><td valign="top" align="center" rowspan="1" colspan="1">26.26 &#177; 4.39</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Depression, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">381 (9.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">44 (18.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3,718 (90.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">198 (81.8%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Anti-depressant medication exposure, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">155 (3.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (9.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3,944 (96.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">218 (90.1%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Hypertension, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1,335 (32.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">86 (35.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.339</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">2,764 (67.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">156 (64.5%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>K-L grades, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0 or 1</td><td valign="top" align="center" rowspan="1" colspan="1">1,134 (27.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">48 (19.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">1,766 (43.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">96 (39.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">833 (20.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">66 (27.3%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">366 (8.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (13.2%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Diabetes, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">505 (12.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (13.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.678</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3,594 (87.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">210 (86.8%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Smoking, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">357 (8.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (9.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.519</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3,742 (91.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">218 (90.1%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Education, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">More than 9 years</td><td valign="top" align="center" rowspan="1" colspan="1">1,036 (25.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">66 (27.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.488</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No more than 9 years</td><td valign="top" align="center" rowspan="1" colspan="1">3,063 (74.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">176 (72.7%)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Data are shown as means (&#177;SD) unless otherwise indicated. BMI, body mass index; K-L, Kellgren-Lawrence.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Multivariable analysis on characteristics grouped by incident knee surgery.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<bold>Odds ratio (95% Confidence interval)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic toggle="yes">P</italic>-value</bold>
</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Baseline BMI</td><td valign="top" align="center" rowspan="1" colspan="1">1.090 (1.054&#8211;1.128)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">1.024 (1.009&#8211;1.039)</td><td valign="top" align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Depression (Reference: No)</td><td valign="top" align="center" rowspan="1" colspan="1">1.670 (1.088&#8211;2.563)</td><td valign="top" align="center" rowspan="1" colspan="1">0.019</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anti-Depressant medication (Reference: No)</td><td valign="top" align="center" rowspan="1" colspan="1">2.004 (1.140&#8211;3.521)</td><td valign="top" align="center" rowspan="1" colspan="1">0.016</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">K-L grade 2 (Reference: K-L grade 0 or 1)</td><td valign="top" align="center" rowspan="1" colspan="1">1.797 (0.924&#8211;1.892)</td><td valign="top" align="center" rowspan="1" colspan="1">0.127</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">K-L grade 3 (Reference: K-L grade 0 or 1)</td><td valign="top" align="center" rowspan="1" colspan="1">1.977 (1.343&#8211;2.909)</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">K-L grade 4 (Reference: K-L grade 0 or 1)</td><td valign="top" align="center" rowspan="1" colspan="1">1.979 (1.241&#8211;3.157)</td><td valign="top" align="center" rowspan="1" colspan="1">0.004</td></tr></tbody></table><table-wrap-foot><p>The logistic regression model included baseline sex, BMI, age, depression, anti-depressant medication, and K-L grades.</p></table-wrap-foot></table-wrap></sec><sec><title>The association between depression/anti-depressant medication and incident opioid use</title><p>A total of 2,227 KOA patients were opioid-na&#239;ve and thus included in the subsequent analysis. During the study period, 568 patients initiated opioid therapies. For univariable analyses, incident opioid use was also significantly associated with depression and exposure to anti-depressant medication (<xref rid="T3" ref-type="table">Table 3</xref>). For multivariable analysis, incident opioid use was significantly associated with depression (OR [95%CI], 1.554 [1.089&#8211;2.215], <italic toggle="yes">P</italic> = 0.015) and exposure to anti-depressant medication (OR [95%CI], 1.813 [1.110&#8211;2.960], <italic toggle="yes">P</italic> = 0.017; <xref rid="T4" ref-type="table">Table 4</xref>).</p><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>Univariable analysis on characteristics grouped by incident opioid use in opioid-na&#239;ve KOA patients.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<bold>No incident opioid use (<italic toggle="yes">n</italic> = 1,659)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold>Incident opioid use (<italic toggle="yes">n</italic> = 568)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic toggle="yes">P-</italic>value</bold>
</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="center" rowspan="1" colspan="1">60.91 &#177; 8.80</td><td valign="top" align="center" rowspan="1" colspan="1">61.05 &#177; 8.25</td><td valign="top" align="center" rowspan="1" colspan="1">0.744</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Sex, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">442 (26.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">150 (26.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.913</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">1,217 (73.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">418 (73.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Baseline BMI, kg/m<sup>2</sup></td><td valign="top" align="center" rowspan="1" colspan="1">25.21 &#177; 3.73</td><td valign="top" align="center" rowspan="1" colspan="1">25.10 &#177; 3.51</td><td valign="top" align="center" rowspan="1" colspan="1">0.525</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Depression, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">128 (7.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">79 (13.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,531 (92.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">489 (86.1%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Anti-depressant medication exposure, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">53 (3.2%)</td><td valign="top" align="center" rowspan="1" colspan="1">43 (7.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">&lt; 0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,606 (96.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">525 (92.4%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Hypertension, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">572 (34.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">180 (31.7%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.225</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,087 (65.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">388 (68.3%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>K-L grades, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0 or 1</td><td valign="top" align="center" rowspan="1" colspan="1">457 (27.5%)</td><td valign="top" align="center" rowspan="1" colspan="1">152 (26.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.968</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">711 (42.9%)</td><td valign="top" align="center" rowspan="1" colspan="1">242 (42.6%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">348 (21.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">123 (21.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">143 (8.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (8.9%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Diabetes, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">206 (12.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">69 (12.1%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.866</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,453 (87.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">499 (87.9%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Smoking, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">140 (8.4%)</td><td valign="top" align="center" rowspan="1" colspan="1">50 (8.8%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.789</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1,519 (91.6%)</td><td valign="top" align="center" rowspan="1" colspan="1">518 (91.2%)</td><td rowspan="1" colspan="1"/></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="4" rowspan="1">
<bold>Education, No. (%)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">More than 9 years</td><td valign="top" align="center" rowspan="1" colspan="1">431 (26.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">138 (24.3%)</td><td valign="top" align="center" rowspan="1" colspan="1">0.427</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No more than 9 years</td><td valign="top" align="center" rowspan="1" colspan="1">1,228 (74.0%)</td><td valign="top" align="center" rowspan="1" colspan="1">430 (75.7%)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>Data are shown as means (&#177; SD) unless otherwise indicated. BMI, body mass index; K-L, Kellgren-Lawrence.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><p>Multivariable analysis on characteristics grouped by incident opioid use in opioid-na&#239;ve KOA patients.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<bold>Odds ratio (95% Confidence interval)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic toggle="yes">P</italic>-value</bold>
</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Depression (Reference: No)</td><td valign="top" align="center" rowspan="1" colspan="1">1.554 (1.089&#8211;2.215)</td><td valign="top" align="center" rowspan="1" colspan="1">0.015</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anti-depressant medication (Reference: No)</td><td valign="top" align="center" rowspan="1" colspan="1">1.813 (1.110&#8211;2.960)</td><td valign="top" align="center" rowspan="1" colspan="1">0.017</td></tr></tbody></table><table-wrap-foot><p>The logistic regression model included baseline sex, BMI, age, depression, anti-depressant medication, and K-L grades.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Although more than 20% of patients with osteoarthritis had depressive symptoms (<xref rid="B10" ref-type="bibr">10</xref>), depression is frequently underdiagnosed and undertreated (<xref rid="B35" ref-type="bibr">35</xref>). Thus, in this study, the prevalence of clinically diagnosed depression in this study was lower than 10%. This fact also once again argued that comorbid depression in KOA patients needed more attention from physicians and patients. A previous study revealed that pain symptoms caused by KOA would largely contribute to the progression of depression (<xref rid="B36" ref-type="bibr">36</xref>). Conversely, patients with depressive disorder have substantial pain over-sensitization in the central nervous system, which leads to more severe symptoms in KOA patients (<xref rid="B37" ref-type="bibr">37</xref>). A pilot study using a combined approach to address both depression and KOA simultaneously yielded more benefits for improving depression, pain, and functional outcomes (<xref rid="B13" ref-type="bibr">13</xref>). In addition, we also demonstrated that depression increased the chance of opioid use in KOA patients. We all know inappropriate prescription of opioids played an important role in the opioid epidemic. The misuse rate of overprescribed opioids was strikingly high, highlighting the urgency of restraining opioid use in KOA patients. Careful management of depression could help to curb the opioid epidemic. Notably, depressed patients initiate opioid therapy slightly more often than non-depressed patients and are twice as likely to transition to long-term use (<xref rid="B18" ref-type="bibr">18</xref>). In studies that carefully control for confounding by indication, it has been shown that long-term opioid therapy increases the risk of incident, recurrent, and treatment-resistant depression (<xref rid="B18" ref-type="bibr">18</xref>). Thus, it is also important to understand the interplay between opioid use and depression in KOA patients.</p><p>Overweight/obesity is a well-established risk factor for both KOA and depression (<xref rid="B36" ref-type="bibr">36</xref>). For KOA management, weight management has previously been recommended as a core approach for achieving long-term benefits, especially for those with overweight/obesity (<xref rid="B38" ref-type="bibr">38</xref>&#8211;<xref rid="B40" ref-type="bibr">40</xref>). For depression, high BMI is a risk factor for the development, progression, and recurrence of depression (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Thus, weight loss might be beneficial for patients with both diseases. However, weight loss greater than 5% was considered clinically relevant, but this goal is generally difficult to reach even after exercise and dieting (<xref rid="B43" ref-type="bibr">43</xref>). Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide, liraglutide, and dulaglutide, are a newly emergent class of weight-reducing drugs (<xref rid="B44" ref-type="bibr">44</xref>). A multicenter prospective study revealed that GLP-1RAs acted as disease-modifying drugs for KOA patients mediated by weight loss (<xref rid="B2" ref-type="bibr">2</xref>). Future research may need to pay more attention to this class of game-changing drugs.</p><p>The current study had several limitations. First, future prospective studies are still needed to validate our findings. Notably, because of the retrospective nature, the patient-reported outcomes were unknown in this study. Second, because of the observational nature of this study, the decision process on surgical treatment and opioid use is a black box for us. Similarly, the current study could not evaluate the disease status of depression. Third, the arthroscopic procedures were ineffective and even harmful to KOA patients. The rationale behind this practice (performing arthroscopic procedures in KOA patients) remained unclear for the current study. We assumed that these receiving arthroscopic procedures reflect the poor control of symptoms caused by KOA. Finally, there is no consensus regarding the diagnosis of depression. We used clinically diagnosed depression, and extrapolation of our conclusion to a different setting should be cautious.</p></sec><sec sec-type="data-availability" id="s5"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="s6"><title>Ethics statement</title><p>The studies involving humans were approved by the Ethics Committee at Jinjiang Municipal Hospital (jjsyyyxll-2012001). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin.</p></sec><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>JZ developed the idea of the study, participated in its design and coordination, and drafted the manuscript. YZ participated in the design of the study and revised the manuscript. YX and YF assessed the radiographs and collected the data. ZL, ZW, and YZ followed up the patients, collected the data, and analyzed the data. LL and XL contributed to the acquisition and interpretation of data. All authors read and approved the final draft.</p></sec></body><back><ack><p>The authors would like to acknowledge all the investigators and staff at participating centers.</p></ack><sec sec-type="COI-statement" id="conf1"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s9"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cross</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E</given-names></name><name name-style="western"><surname>Hoy</surname><given-names>D</given-names></name><name name-style="western"><surname>Nolte</surname><given-names>S</given-names></name><name name-style="western"><surname>Ackerman</surname><given-names>I</given-names></name><name name-style="western"><surname>Fransen</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study</article-title>. <source>Ann Rheum Dis.</source> (<year>2014</year>) <volume>73</volume>:<fpage>1323</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204763</pub-id><pub-id pub-id-type="pmid">24553908</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>F</given-names></name><name name-style="western"><surname>Jin</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort</article-title>. <source>Ann Rheum Dis.</source> (<year>2023</year>) <volume>82</volume>:<fpage>1218</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1136/ard-2023-223845</pub-id><pub-id pub-id-type="pmid">37258065</pub-id><pub-id pub-id-type="pmcid">PMC10423473</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Schofield</surname><given-names>D</given-names></name><name name-style="western"><surname>Callander</surname><given-names>E</given-names></name></person-group>. <article-title>The individual and socioeconomic impact of osteoarthritis</article-title>. <source>Nat Rev Rheumatol.</source> (<year>2014</year>) <volume>10</volume>:<fpage>437</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2014.44</pub-id><pub-id pub-id-type="pmid">24662640</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>GBD</surname><given-names>2019 Risk Factors Collaborators</given-names></name></person-group>. <article-title>Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet.</source> (<year>2020</year>) <volume>396</volume>:<fpage>1223</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30752-2</pub-id><pub-id pub-id-type="pmid">33069327</pub-id><pub-id pub-id-type="pmcid">PMC7566194</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Diao</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019</article-title>. <source>Arthritis Rheumatol.</source> (<year>2022</year>) <volume>74</volume>:<fpage>1172</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1002/art.42089</pub-id><pub-id pub-id-type="pmid">35233975</pub-id><pub-id pub-id-type="pmcid">PMC9543105</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhi</surname><given-names>GS</given-names></name><name name-style="western"><surname>Mann</surname><given-names>JJ</given-names></name></person-group>. <article-title>Depression</article-title>. <source>Lancet.</source> (<year>2018</year>) <volume>392</volume>:<fpage>2299</fpage>&#8211;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(18)31948-2</pub-id><pub-id pub-id-type="pmid">30396512</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Dyne</surname><given-names>A</given-names></name><name name-style="western"><surname>Moy</surname><given-names>J</given-names></name><name name-style="western"><surname>Wash</surname><given-names>K</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>L</given-names></name><name name-style="western"><surname>Skow</surname><given-names>T</given-names></name><name name-style="western"><surname>Roesch</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Health, psychological and demographic predictors of depression in people with fibromyalgia and osteoarthritis</article-title>. <source>Int J Environ Res Public Health.</source> (<year>2022</year>) <volume>19</volume>:<fpage>3413</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph19063413</pub-id><pub-id pub-id-type="pmid">35329109</pub-id><pub-id pub-id-type="pmcid">PMC8950397</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobs</surname><given-names>CA</given-names></name><name name-style="western"><surname>Vranceanu</surname><given-names>AM</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>KL</given-names></name><name name-style="western"><surname>Lattermann</surname><given-names>C</given-names></name></person-group>. <article-title>Rapid progression of knee pain and osteoarthritis biomarkers greatest for patients with combined obesity and depression: data from the osteoarthritis initiative</article-title>. <source>Cartilage.</source> (<year>2020</year>) <volume>11</volume>:<fpage>38</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1177/1947603518777577</pub-id><pub-id pub-id-type="pmid">29855190</pub-id><pub-id pub-id-type="pmcid">PMC6921961</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marks</surname><given-names>R</given-names></name></person-group>. <article-title>Comorbid depression and anxiety impact hip osteoarthritis disability</article-title>. <source>Disabil Health J.</source> (<year>2009</year>) <volume>2</volume>:<fpage>27</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.dhjo.2008.10.001</pub-id><pub-id pub-id-type="pmid">21122740</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stubbs</surname><given-names>B</given-names></name><name name-style="western"><surname>Aluko</surname><given-names>Y</given-names></name><name name-style="western"><surname>Myint</surname><given-names>PK</given-names></name><name name-style="western"><surname>Smith</surname><given-names>TO</given-names></name></person-group>. <article-title>Prevalence of depressive symptoms and anxiety in osteoarthritis: a systematic review and meta-analysis</article-title>. <source>Age Ageing.</source> (<year>2016</year>) <volume>45</volume>:<fpage>228</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/ageing/afw001</pub-id><pub-id pub-id-type="pmid">26795974</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gleicher</surname><given-names>Y</given-names></name><name name-style="western"><surname>Croxford</surname><given-names>R</given-names></name><name name-style="western"><surname>Hochman</surname><given-names>J</given-names></name><name name-style="western"><surname>Hawker</surname><given-names>G</given-names></name></person-group>. <article-title>A prospective study of mental health care for comorbid depressed mood in older adults with painful osteoarthritis</article-title>. <source>BMC Psychiatry.</source> (<year>2011</year>) <volume>11</volume>:<fpage>147</fpage>. <pub-id pub-id-type="doi">10.1186/1471-244x-11-147</pub-id><pub-id pub-id-type="pmid">21910895</pub-id><pub-id pub-id-type="pmcid">PMC3184052</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rathbun</surname><given-names>AM</given-names></name><name name-style="western"><surname>Schuler</surname><given-names>MS</given-names></name><name name-style="western"><surname>Stuart</surname><given-names>EA</given-names></name><name name-style="western"><surname>Shardell</surname><given-names>MD</given-names></name><name name-style="western"><surname>Yau</surname><given-names>MS</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>Depression subtypes in individuals with or at risk for symptomatic knee osteoarthritis</article-title>. <source>Arthritis Care Res.</source> (<year>2020</year>) <volume>72</volume>:<fpage>669</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1002/acr.23898</pub-id><pub-id pub-id-type="pmid">30951261</pub-id><pub-id pub-id-type="pmcid">PMC7176152</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>EH</given-names></name></person-group>. <article-title>Depression and osteoarthritis</article-title>. <source>Am J Med.</source> (<year>2008</year>) <volume>121</volume>(<issue>11 Suppl 2</issue>):<fpage>S16</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2008.09.009</pub-id><pub-id pub-id-type="pmid">18954588</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geenen</surname><given-names>R</given-names></name><name name-style="western"><surname>Overman</surname><given-names>CL</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>R</given-names></name><name name-style="western"><surname>&#197;senl&#246;f</surname><given-names>P</given-names></name><name name-style="western"><surname>Capela</surname><given-names>S</given-names></name><name name-style="western"><surname>Huisinga</surname><given-names>KL</given-names></name><etal/></person-group>. <article-title>EULAR recommendations for the health professional's approach to pain management in inflammatory arthritis and osteoarthritis</article-title>. <source>Ann Rheum Dis.</source> (<year>2018</year>) <volume>77</volume>:<fpage>797</fpage>&#8211;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2017-212662</pub-id><pub-id pub-id-type="pmid">29724726</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolasinski</surname><given-names>SL</given-names></name><name name-style="western"><surname>Neogi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Oatis</surname><given-names>C</given-names></name><name name-style="western"><surname>Guyatt</surname><given-names>G</given-names></name><name name-style="western"><surname>Block</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>2019 american college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee</article-title>. <source>Arthritis Care Res.</source> (<year>2020</year>) <volume>72</volume>:<fpage>149</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/acr.24131</pub-id><pub-id pub-id-type="pmid">31908149</pub-id><pub-id pub-id-type="pmcid">PMC11488261</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Compton</surname><given-names>WM</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>M</given-names></name><name name-style="western"><surname>Wargo</surname><given-names>E</given-names></name></person-group>. <article-title>Prescription opioid abuse: problems and responses</article-title>. <source>Prev Med.</source> (<year>2015</year>) <volume>80</volume>:<fpage>5</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2015.04.003</pub-id><pub-id pub-id-type="pmid">25871819</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bates</surname><given-names>C</given-names></name><name name-style="western"><surname>Laciak</surname><given-names>R</given-names></name><name name-style="western"><surname>Southwick</surname><given-names>A</given-names></name><name name-style="western"><surname>Bishoff</surname><given-names>J</given-names></name></person-group>. <article-title>Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice</article-title>. <source>J Urol.</source> (<year>2011</year>) <volume>185</volume>:<fpage>551</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2010.09.088</pub-id><pub-id pub-id-type="pmid">21168869</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>MD</given-names></name></person-group>. <article-title>Depression effects on long-term prescription opioid use, abuse, and addiction</article-title>. <source>Clin J Pain.</source> (<year>2018</year>) <volume>34</volume>:<fpage>878</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1097/ajp.0000000000000603</pub-id><pub-id pub-id-type="pmid">29505419</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huizinga</surname><given-names>JL</given-names></name><name name-style="western"><surname>Stanley</surname><given-names>EE</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>JK</given-names></name><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Paltiel</surname><given-names>AD</given-names></name><etal/></person-group>. <article-title>Societal cost of opioid use in symptomatic knee osteoarthritis patients in the United States</article-title>. <source>Arthritis Care Res.</source> (<year>2022</year>) <volume>74</volume>:<fpage>1349</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/acr.24581</pub-id><pub-id pub-id-type="pmid">33629485</pub-id><pub-id pub-id-type="pmcid">PMC8382774</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trouvin</surname><given-names>AP</given-names></name><name name-style="western"><surname>Berenbaum</surname><given-names>F</given-names></name><name name-style="western"><surname>Perrot</surname><given-names>S</given-names></name></person-group>. <article-title>The opioid epidemic: helping rheumatologists prevent a crisis</article-title>. <source>RMD Open.</source> (<year>2019</year>) <volume>5</volume>:<fpage>e001029</fpage>. <pub-id pub-id-type="doi">10.1136/rmdopen-2019-001029</pub-id><pub-id pub-id-type="pmid">31452932</pub-id><pub-id pub-id-type="pmcid">PMC6691510</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Felson</surname><given-names>D</given-names></name></person-group>. <article-title>Tramadol and mortality in patients with osteoarthritis</article-title>. <source>JAMA.</source> (<year>2019</year>) <volume>322</volume>:<fpage>465</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2019.7216</pub-id><pub-id pub-id-type="pmcid">PMC10544791</pub-id><pub-id pub-id-type="pmid">31386126</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeMik</surname><given-names>DE</given-names></name><name name-style="western"><surname>Bedard</surname><given-names>NA</given-names></name><name name-style="western"><surname>Dowdle</surname><given-names>SB</given-names></name><name name-style="western"><surname>Burnett</surname><given-names>RA</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>MA</given-names></name><name name-style="western"><surname>Callaghan</surname><given-names>JJ</given-names></name></person-group>. <article-title>Are we still prescribing opioids for osteoarthritis?</article-title><source>J Arthroplasty.</source> (<year>2017</year>) <volume>32</volume>:<fpage>3578</fpage>&#8211;<lpage>82</lpage>.e1. <pub-id pub-id-type="doi">10.1016/j.arth.2017.07.030</pub-id><pub-id pub-id-type="pmid">28887019</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Browne</surname><given-names>CA</given-names></name><name name-style="western"><surname>Lucki</surname><given-names>I</given-names></name></person-group>. <article-title>Targeting opioid dysregulation in depression for the development of novel therapeutics</article-title>. <source>Pharmacol Ther.</source> (<year>2019</year>) <volume>201</volume>:<fpage>51</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2019.04.009</pub-id><pub-id pub-id-type="pmid">31051197</pub-id><pub-id pub-id-type="pmcid">PMC6859062</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>AH</given-names></name><name name-style="western"><surname>Orr</surname><given-names>MF</given-names></name><name name-style="western"><surname>Shepherd</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bakhshaie</surname><given-names>J</given-names></name><name name-style="western"><surname>Ditre</surname><given-names>JW</given-names></name><name name-style="western"><surname>Buckner</surname><given-names>JD</given-names></name><etal/></person-group>. <article-title>Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation</article-title>. <source>J Behav Med.</source> (<year>2021</year>) <volume>44</volume>:<fpage>66</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s10865-020-00169-8</pub-id><pub-id pub-id-type="pmid">32594288</pub-id><pub-id pub-id-type="pmcid">PMC11862901</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayor</surname><given-names>S</given-names></name></person-group>. <article-title>Long term opioid analgesic use is linked to increased risk of depression, study shows</article-title>. <source>BMJ.</source> (<year>2016</year>) <volume>352</volume>:<fpage>i134</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.i134</pub-id><pub-id pub-id-type="pmid">26769774</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thielke</surname><given-names>SM</given-names></name><name name-style="western"><surname>Shortreed</surname><given-names>SM</given-names></name><name name-style="western"><surname>Saunders</surname><given-names>K</given-names></name><name name-style="western"><surname>Turner</surname><given-names>JA</given-names></name><name name-style="western"><surname>LeResche</surname><given-names>L</given-names></name><name name-style="western"><surname>Von Korff</surname><given-names>M</given-names></name></person-group>. <article-title>A prospective study of predictors of long-term opioid use among patients with chronic noncancer pain</article-title>. <source>Clin J Pain.</source> (<year>2017</year>) <volume>33</volume>:<fpage>198</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1097/ajp.0000000000000409</pub-id><pub-id pub-id-type="pmid">27428547</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skou</surname><given-names>ST</given-names></name><name name-style="western"><surname>Koes</surname><given-names>BW</given-names></name><name name-style="western"><surname>Gr&#248;nne</surname><given-names>DT</given-names></name><name name-style="western"><surname>Young</surname><given-names>J</given-names></name><name name-style="western"><surname>Roos</surname><given-names>EM</given-names></name></person-group>. <article-title>Comparison of three sets of clinical classification criteria for knee osteoarthritis: a cross-sectional study of 13,459 patients treated in primary care</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2020</year>) <volume>28</volume>:<fpage>167</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2019.09.003</pub-id><pub-id pub-id-type="pmid">31539621</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reijman</surname><given-names>M</given-names></name><name name-style="western"><surname>Hazes</surname><given-names>JM</given-names></name><name name-style="western"><surname>Koes</surname><given-names>BW</given-names></name><name name-style="western"><surname>Verhagen</surname><given-names>AP</given-names></name><name name-style="western"><surname>Bierma-Zeinstra</surname><given-names>SM</given-names></name></person-group>. <article-title>Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal</article-title>. <source>Ann Rheum Dis.</source> (<year>2004</year>) <volume>63</volume>:<fpage>226</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2003.010348</pub-id><pub-id pub-id-type="pmid">14962953</pub-id><pub-id pub-id-type="pmcid">PMC1754907</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glyn-Jones</surname><given-names>S</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Agricola</surname><given-names>R</given-names></name><name name-style="western"><surname>Price</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>TL</given-names></name><name name-style="western"><surname>Weinans</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Osteoarthritis</article-title>. <source>Lancet.</source> (<year>2015</year>) <volume>386</volume>:<fpage>376</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(14)60802-3</pub-id><pub-id pub-id-type="pmid">25748615</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martel-Pelletier</surname><given-names>J</given-names></name><name name-style="western"><surname>Barr</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Cicuttini</surname><given-names>FM</given-names></name><name name-style="western"><surname>Conaghan</surname><given-names>PG</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>C</given-names></name><name name-style="western"><surname>Goldring</surname><given-names>MB</given-names></name><etal/></person-group>. <article-title>Osteoarthritis</article-title>. <source>Nat Rev Dis Primers.</source> (<year>2016</year>) <volume>2</volume>:<fpage>16072</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2016.72</pub-id><pub-id pub-id-type="pmid">27734845</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moseley</surname><given-names>JB</given-names></name><name name-style="western"><surname>O'Malley</surname><given-names>K</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Menke</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Brody</surname><given-names>BA</given-names></name><name name-style="western"><surname>Kuykendall</surname><given-names>DH</given-names></name><etal/></person-group>. <article-title>A controlled trial of arthroscopic surgery for osteoarthritis of the knee</article-title>. <source>N Engl J Med.</source> (<year>2002</year>) <volume>347</volume>:<fpage>81</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa013259</pub-id><pub-id pub-id-type="pmid">12110735</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sihvonen</surname><given-names>R</given-names></name><name name-style="western"><surname>Paavola</surname><given-names>M</given-names></name><name name-style="western"><surname>Malmivaara</surname><given-names>A</given-names></name><name name-style="western"><surname>It&#228;l&#228;</surname><given-names>A</given-names></name><name name-style="western"><surname>Joukainen</surname><given-names>A</given-names></name><name name-style="western"><surname>Kalske</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Arthroscopic partial meniscectomy for a degenerative meniscus tear: a 5 year follow-up of the placebo-surgery controlled FIDELITY (Finnish Degenerative Meniscus Lesion Study) trial</article-title>. <source>Br J Sports Med.</source> (<year>2020</year>) <volume>54</volume>:<fpage>1332</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/bjsports-2020-102813</pub-id><pub-id pub-id-type="pmid">32855201</pub-id><pub-id pub-id-type="pmcid">PMC7606577</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stahel</surname><given-names>PF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Hutfless</surname><given-names>S</given-names></name><name name-style="western"><surname>McCarty</surname><given-names>E</given-names></name><name name-style="western"><surname>Mehler</surname><given-names>PS</given-names></name><name name-style="western"><surname>Osgood</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>Surgeon practice patterns of arthroscopic partial meniscectomy for degenerative disease in the United States: a measure of low-value care</article-title>. <source>JAMA Surg.</source> (<year>2018</year>) <volume>153</volume>:<fpage>494</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1001/jamasurg.2017.6235</pub-id><pub-id pub-id-type="pmid">29490362</pub-id><pub-id pub-id-type="pmcid">PMC5875312</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rickert</surname><given-names>J</given-names></name></person-group>. <article-title>On patient safety: orthopaedic surgeons must stop performing arthroscopic partial meniscectomy on patients with arthritic knees</article-title>. <source>Clin Orthop Relat Res.</source> (<year>2020</year>) <volume>478</volume>:<fpage>28</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/corr.0000000000001072</pub-id><pub-id pub-id-type="pmid">31809288</pub-id><pub-id pub-id-type="pmcid">PMC7000064</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>VanItallie</surname><given-names>TB</given-names></name></person-group>. <article-title>Subsyndromal depression in the elderly: underdiagnosed and undertreated</article-title>. <source>Metabolism.</source> (<year>2005</year>) <volume>54</volume>(<issue>5 Suppl 1</issue>):<fpage>39</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.metabol.2005.01.012</pub-id><pub-id pub-id-type="pmid">15877312</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Tu</surname><given-names>L</given-names></name><name name-style="western"><surname>Cicuttini</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Antony</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Depression in patients with knee osteoarthritis: risk factors and associations with joint symptoms</article-title>. <source>BMC Musculoskelet Disord.</source> (<year>2021</year>) <volume>22</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/s12891-020-03875-1</pub-id><pub-id pub-id-type="pmid">33413273</pub-id><pub-id pub-id-type="pmcid">PMC7791830</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Ruiz</surname><given-names>M</given-names></name><name name-style="western"><surname>Losilla</surname><given-names>JM</given-names></name><name name-style="western"><surname>Monfort</surname><given-names>J</given-names></name><name name-style="western"><surname>Portell</surname><given-names>M</given-names></name><name name-style="western"><surname>Guti&#233;rrez</surname><given-names>T</given-names></name><name name-style="western"><surname>Poca</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Central sensitization in knee osteoarthritis and fibromyalgia: beyond depression and anxiety</article-title>. <source>PLoS ONE.</source> (<year>2019</year>) <volume>14</volume>:<fpage>e0225836</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0225836</pub-id><pub-id pub-id-type="pmid">31805099</pub-id><pub-id pub-id-type="pmcid">PMC6894784</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arden</surname><given-names>NK</given-names></name><name name-style="western"><surname>Perry</surname><given-names>TA</given-names></name><name name-style="western"><surname>Bannuru</surname><given-names>RR</given-names></name><name name-style="western"><surname>Bruy&#232;re</surname><given-names>O</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>C</given-names></name><name name-style="western"><surname>Haugen</surname><given-names>IK</given-names></name><etal/></person-group>. <article-title>Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines</article-title>. <source>Nat Rev Rheumatol.</source> (<year>2021</year>) <volume>17</volume>:<fpage>59</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/s41584-020-00523-9</pub-id><pub-id pub-id-type="pmid">33116279</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fernandes</surname><given-names>L</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>KB</given-names></name><name name-style="western"><surname>Bijlsma</surname><given-names>JW</given-names></name><name name-style="western"><surname>Andreassen</surname><given-names>O</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>P</given-names></name><name name-style="western"><surname>Conaghan</surname><given-names>PG</given-names></name><etal/></person-group>. <article-title>EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis</article-title>. <source>Ann Rheum Dis.</source> (<year>2013</year>) <volume>72</volume>:<fpage>1125</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2012-202745</pub-id><pub-id pub-id-type="pmid">23595142</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolasinski</surname><given-names>SL</given-names></name><name name-style="western"><surname>Neogi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Oatis</surname><given-names>C</given-names></name><name name-style="western"><surname>Guyatt</surname><given-names>G</given-names></name><name name-style="western"><surname>Block</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee</article-title>. <source>Arthritis Rheumatol.</source> (<year>2020</year>) <volume>72</volume>:<fpage>220</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/art.41142</pub-id><pub-id pub-id-type="pmid">31908163</pub-id><pub-id pub-id-type="pmcid">PMC10518852</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>DA</given-names></name><name name-style="western"><surname>Coutinho</surname><given-names>E</given-names></name><name name-style="western"><surname>Ferriani</surname><given-names>LO</given-names></name><name name-style="western"><surname>Viana</surname><given-names>MC</given-names></name></person-group>. <article-title>Depression subtypes and obesity in adults: a systematic review and meta-analysis</article-title>. <source>Obes Rev.</source> (<year>2020</year>) <volume>21</volume>:<fpage>e12966</fpage>. <pub-id pub-id-type="doi">10.1111/obr.12966</pub-id><pub-id pub-id-type="pmid">31724325</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahle</surname><given-names>BW</given-names></name><name name-style="western"><surname>Breslin</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanderson</surname><given-names>K</given-names></name><name name-style="western"><surname>Patton</surname><given-names>G</given-names></name><name name-style="western"><surname>Dwyer</surname><given-names>T</given-names></name><name name-style="western"><surname>Venn</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association between depression, anxiety and weight change in young adults</article-title>. <source>BMC Psychiatry.</source> (<year>2019</year>) <volume>19</volume>:<fpage>398</fpage>. <pub-id pub-id-type="doi">10.1186/s12888-019-2385-z</pub-id><pub-id pub-id-type="pmid">31842829</pub-id><pub-id pub-id-type="pmcid">PMC6916239</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Runhaar</surname><given-names>J</given-names></name><name name-style="western"><surname>Kloppenburg</surname><given-names>M</given-names></name><name name-style="western"><surname>Boers</surname><given-names>M</given-names></name><name name-style="western"><surname>Bijlsma</surname><given-names>JWJ</given-names></name><name name-style="western"><surname>Bierma-Zeinstra</surname><given-names>SMA</given-names></name></person-group>. <article-title>Diagnosis of early stage knee osteoarthritis based on early clinical course: data from the CHECK cohort</article-title>. <source>Arthritis Res Ther.</source> (<year>2021</year>) <volume>23</volume>:<fpage>217</fpage>. <pub-id pub-id-type="doi">10.1186/s13075-021-02598-5</pub-id><pub-id pub-id-type="pmid">34412670</pub-id><pub-id pub-id-type="pmcid">PMC8375192</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubino</surname><given-names>DM</given-names></name><name name-style="western"><surname>Greenway</surname><given-names>FL</given-names></name><name name-style="western"><surname>Khalid</surname><given-names>U</given-names></name><name name-style="western"><surname>O'Neil</surname><given-names>PM</given-names></name><name name-style="western"><surname>Rosenstock</surname><given-names>J</given-names></name><name name-style="western"><surname>S&#248;rrig</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial</article-title>. <source>JAMA.</source> (<year>2022</year>) <volume>327</volume>:<fpage>138</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2021.23619</pub-id><pub-id pub-id-type="pmid">35015037</pub-id><pub-id pub-id-type="pmcid">PMC8753508</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>